Microbial Translocation Correlates with the Severity of Both HIV-1 and HIV-2 Infections

Journal of Infectious Diseases

Volumn 201, Issue 8, 2010, Pages 1150-1154

  Nowroozalizadeh, Salma ^a,b   Månsson, Fredrik ^c   Da Silva, Zacarias ^e,f   Repits, Johanna ^d   Dabo, Braima ^f   Pereira, Carla ^f   Biague, Antonio ^f   Albert, Jan ^a,b   Nielsen, Jens ^e   Aaby, Peter ^e   Fenyö, Eva Maria ^d   Norrgren, Hans ^c   Holmgren, Birgitts ^d   Jansson, Marianne ^a,b,d  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b Department of Microbiology Tumor   (United States)

^c LUND UNIVERSITY   (Sweden)

^d Department of Laboratory Medicine ^*  (Sweden)

^e Studies of the Epidemiology of Epilepsy in Demographic Surveillance Systems   (United States)

^f National Laboratory for Public Health   (Guinea-Bissau)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MITOGENIC AGENT; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BACTERIAL TRANSLOCATION; CD4+ T LYMPHOCYTE; CELL LOSS; CONTROLLED STUDY; GUINEA-BISSAU; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; VIRUS IMMUNITY; VIRUS LOAD;

BACTERIAL TRANSLOCATION; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; LIPOPOLYSACCHARIDES; MALE; TOLL-LIKE RECEPTORS; VIRAL LOAD;

EID: 77950267769     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/651430     Document Type: Article

References (15)

1. Douek DC, Roederer M, Koup RA. Emerging concepts in the im-munopathogenesis of AIDS. Annu Rev Med 2009;60: 471-1184
2. Levy JA. HIV pathogenesis: 25 years of progress and persistent chal-lenges. AIDS 2009;23: 147-160.
3. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006;12: 1365-1371.
4. Jiang W, Lederman MM, Hunt P, et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune res-toration in persons with antiretroviral-treated HIV infection. J Infect Dis 2009;199: 1177-1185.
5. de Silva TI, Cotten M, Rowland-Jones SL. HIV-2: the forgotten AIDS virus. Trends Microbiol 2008;16: 588-595.
6. Michel P, Balde AT, Roussilhon C, Aribot G, Sarthou JL, Gougeon ML. Reduced immune activation and T cell apoptosis in human immu-nodeficiency virus type 2 compared with type 1 : correlation of T cell apoptosis with β2 microglobulin concentration and disease evolution. J Infect Dis 2000;181: 64-75.
7. Sousa AE, Carneiro J, Meier-Schellersheim M, Grossman Z, Victorino RM. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol 2002;169: 3400-3406.
8. Nowroozalizadeh S, Mansson F, da Silva Z, et al. Studies on Toll-like receptor stimuli responsiveness in HIV-1 and HIV-2 infections. Cy-tokine 2009;46: 325-331.
9. Norrgren H, Da Silva Z, Biague A, Andersson S, Biberfeld G. Clinical progression in early and late stages of disease in a cohort of individuals infected with human immunodeficiency virus-2 in Guinea-Bissau. Scand J Infect Dis 2003;35: 265-272.
10. da Silva ZJ, Oliveira I, Andersen A, et al. Changes in prevalence and incidence of HIV-1, HIV-2 and dual infections in urban areas of Bissau, Guinea-Bissau: is HIV-2 disappearing? AIDS 2008;22: 1195-1202.
11. Redd AD, Dabitao D, Bream JH, et al. Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa. Proc Natl Acad Sci U S A 2009;106: 6718-6723.
12. Meier A, Chang JJ, Chan ES, et al. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 2009;15: 955-959.
13. Boasso A, Shearer GM, Chougnet C. Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it? J Intern Med 2009;265: 78-96.
14. Ayash-Rashkovsky M, Bentwich Z, Borkow G. TLR9 expression is re-lated to immune activation but is impaired in individuals with chronic immune activation. Int J Biochem Cell Biol 2005;37: 2380-2394.
15. Schroecksnadel K, Winkler C, Sarcletti M, et al. Parameters of soluble immune activation in vivo correlate negatively with the proliferative capacity of peripheral blood mononuclear cells in vitro in HIV-infected patients. J Acquir Immune Defic Syndr 2009;50: 354-359.